Hypertension, seizures, and epilepsy: a review on pathophysiology and management.


Journal

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 19 02 2019
accepted: 23 04 2019
pubmed: 6 5 2019
medline: 13 2 2020
entrez: 6 5 2019
Statut: ppublish

Résumé

Epilepsy and hypertension are common chronic conditions, both showing high prevalence in older age groups. This review outlines current experimental and clinical evidence on both direct and indirect role of hypertension in epileptogenesis and discusses the principles of drug treatment in patients with hypertension and epilepsy. We selected English-written articles on epilepsy, hypertension, stroke, and cerebrovascular disease until December, 2018. Renin-angiotensin system might play a central role in the direct interaction between hypertension and epilepsy, but other mechanisms may be contemplated. Large-artery stroke, small vessel disease and posterior reversible leukoencephalopathy syndrome are hypertension-related brain lesions able to determine epilepsy by indirect mechanisms. The role of hypertension as an independent risk factor for post-stroke epilepsy has not been demonstrated. The role of hypertension-related small vessel disease in adult-onset epilepsy has been demonstrated. Posterior reversible encephalopathy syndrome is an acute condition, often caused by a hypertensive crisis, associated with the occurrence of acute symptomatic seizures. Chronic antiepileptic treatment should consider the risk of drug-drug interactions with antihypertensives. Current evidence from preclinical and clinical studies supports the vision that hypertension may be a cause of seizures and epilepsy through direct or indirect mechanisms. In both post-stroke epilepsy and small vessel disease-associated epilepsy, chronic antiepileptic treatment is recommended. In posterior reversible encephalopathy syndrome blood pressure must be rapidly lowered and prompt antiepileptic treatment should be initiated.

Sections du résumé

BACKGROUND BACKGROUND
Epilepsy and hypertension are common chronic conditions, both showing high prevalence in older age groups. This review outlines current experimental and clinical evidence on both direct and indirect role of hypertension in epileptogenesis and discusses the principles of drug treatment in patients with hypertension and epilepsy.
METHODS METHODS
We selected English-written articles on epilepsy, hypertension, stroke, and cerebrovascular disease until December, 2018.
RESULTS RESULTS
Renin-angiotensin system might play a central role in the direct interaction between hypertension and epilepsy, but other mechanisms may be contemplated. Large-artery stroke, small vessel disease and posterior reversible leukoencephalopathy syndrome are hypertension-related brain lesions able to determine epilepsy by indirect mechanisms. The role of hypertension as an independent risk factor for post-stroke epilepsy has not been demonstrated. The role of hypertension-related small vessel disease in adult-onset epilepsy has been demonstrated. Posterior reversible encephalopathy syndrome is an acute condition, often caused by a hypertensive crisis, associated with the occurrence of acute symptomatic seizures. Chronic antiepileptic treatment should consider the risk of drug-drug interactions with antihypertensives.
CONCLUSIONS CONCLUSIONS
Current evidence from preclinical and clinical studies supports the vision that hypertension may be a cause of seizures and epilepsy through direct or indirect mechanisms. In both post-stroke epilepsy and small vessel disease-associated epilepsy, chronic antiepileptic treatment is recommended. In posterior reversible encephalopathy syndrome blood pressure must be rapidly lowered and prompt antiepileptic treatment should be initiated.

Identifiants

pubmed: 31055731
doi: 10.1007/s10072-019-03913-4
pii: 10.1007/s10072-019-03913-4
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1775-1783

Références

J Neurol Neurosurg Psychiatry. 1999 May;66(5):561-8
pubmed: 10209164
Acta Neurol Scand. 1999 May;99(5):265-8
pubmed: 10348154
Exp Neurol. 1979 Nov;66(2):277-84
pubmed: 114406
Neurology. 2001 Jul 24;57(2):200-6
pubmed: 11468303
Cerebrovasc Dis. 2001;12(4):331-4
pubmed: 11721104
Arch Neurol. 2002 Feb;59(2):195-201
pubmed: 11843689
Eur J Neurol. 2002 Jul;9(4):365-8
pubmed: 12099919
Neurology. 2002 Oct 8;59(7):1028-33
pubmed: 12370457
Neurology. 2003 May 13;60(9):1534-6
pubmed: 12743248
Am J Obstet Gynecol. 2004 Jun;190(6):1520-6
pubmed: 15284724
Life Sci. 2005 Jan 14;76(9):955-70
pubmed: 15607326
Epileptic Disord. 2005 Jun;7(2):91-5
pubmed: 15929910
Epilepsy Res. 2006 Jan;68 Suppl 1:S39-48
pubmed: 16384689
Neurol Sci. 2006 Jul;27(3):187-9
pubmed: 16897633
J Neurol Sci. 2007 Dec 15;263(1-2):75-8
pubmed: 17610904
Neuroscience. 2007 Aug 10;148(1):314-24
pubmed: 17629408
Epilepsia. 2008 Jan;49(1):117-24
pubmed: 17672852
Neurology. 2007 Aug 28;69(9):894-7
pubmed: 17724292
Arch Neurol. 2008 Feb;65(2):205-10
pubmed: 18268188
Epilepsia. 2008 Aug;49(8):1348-57
pubmed: 18363708
Vasc Health Risk Manag. 2008;4(3):715-20
pubmed: 18827922
Eur Neurol. 2009;61(3):159-63
pubmed: 19092253
Epilepsy Res. 2009 Nov;87(1):1-11
pubmed: 19744830
Neurology. 1991 May;41(5):740-2
pubmed: 2027492
Clin Sci (Lond). 2010 Aug 17;119(11):477-82
pubmed: 20533906
Lancet. 2010 Jul 10;376(9735):112-23
pubmed: 20561675
Neurology. 2011 Nov 15;77(20):1794-800
pubmed: 21975203
Neurology. 2011 Nov 15;77(20):1785-93
pubmed: 21975208
J Neurol. 2012 Jul;259(7):1383-9
pubmed: 22189837
Lancet Neurol. 2012 Mar;11(3):272-82
pubmed: 22341035
Neurosurgery. 1990 Oct;27(4):578-81
pubmed: 2234361
Eur J Neurol. 2012 Oct;19(10):1361-6
pubmed: 22680974
Neuroepidemiology. 2012;39(1):45-50
pubmed: 22777596
Clin Neurol Neurosurg. 2013 May;115(5):591-6
pubmed: 22840415
Epilepsia. 2013 Jan;54(1):11-27
pubmed: 23016553
PLoS One. 2013;8(2):e53455
pubmed: 23393549
Am J Obstet Gynecol. 2013 Jun;208(6):468.e1-6
pubmed: 23395926
Acta Neurol Scand. 2013 Jun;127(6):427-30
pubmed: 23398544
Lancet Neurol. 2013 Aug;12(8):822-38
pubmed: 23867200
PLoS One. 2013 Nov 13;8(11):e80852
pubmed: 24236205
Expert Opin Drug Saf. 2014 Sep;13 Suppl 1:S41-55
pubmed: 25171158
PLoS One. 2014 Nov 19;9(11):e113670
pubmed: 25409522
Epilepsy Res. 2015 Jan;109:1-8
pubmed: 25524836
Epilepsia. 2015 Apr;56(4):564-8
pubmed: 25690439
Epilepsy Behav. 2015 May;46:66-71
pubmed: 25922088
Epilepsy Behav. 2015 Jul;48:70-4
pubmed: 26071927
Neuroepidemiology. 2015;45(1):50-8
pubmed: 26227564
Cell Mol Neurobiol. 2016 Aug;36(6):927-941
pubmed: 26464042
Seizure. 2016 Jan;34:90-4
pubmed: 26760446
Pharmacol Res. 2016 Apr;106:21-26
pubmed: 26896787
J Cereb Blood Flow Metab. 2017 Feb;37(2):644-656
pubmed: 26933133
Rev Neurol (Paris). 2016 Jun-Jul;172(6-7):384-8
pubmed: 27371132
Epilepsia. 2016 Aug;57(8):1205-14
pubmed: 27381481
Brain Res Bull. 2017 Apr;130:245-250
pubmed: 28214547
Pregnancy Hypertens. 2017 Jan;7:44-49
pubmed: 28279447
Brain Res Bull. 2017 May;131:93-99
pubmed: 28373149
Neurology. 2017 Jun 6;88(23):2169-2175
pubmed: 28476758
Life Sci. 2018 Jan 15;193:40-46
pubmed: 29223539
Lancet Neurol. 2018 Feb;17(2):143-152
pubmed: 29413315
Neurologist. 2018 Mar;23(2):65-66
pubmed: 29494439
Nat Rev Neurol. 2018 Jul;14(7):387-398
pubmed: 29802354
JAMA Neurol. 2018 Nov 1;75(11):1375-1382
pubmed: 30039175
JAMA Neurol. 2018 Oct 1;75(10):1273-1281
pubmed: 30167649
Ann Neurol. 1985 May;17(5):497-504
pubmed: 4004172
Br Med J. 1973 Mar 3;1(5852):507-10
pubmed: 4692673
Acta Anaesthesiol Scand Suppl. 1971;45:78-80
pubmed: 5290078
Stroke. 1995 Jul;26(7):1293-301
pubmed: 7604429
Neurology. 1993 Feb;43(2):425-8
pubmed: 8437714
Epilepsia. 1993 May-Jun;34(3):453-68
pubmed: 8504780
J Neurol Sci. 1995 Jun;130(2):171-7
pubmed: 8586982
Epilepsia. 1996 Aug;37(8):736-41
pubmed: 8764811
Epilepsia. 1997 Nov;38(11):1216-20
pubmed: 9579923
Acta Neuropathol. 1998 Aug;96(2):163-71
pubmed: 9705132

Auteurs

Sara Gasparini (S)

Medical and Surgical Sciences Department, School of Medicine, Magna Græcia University of Catanzaro, Viale Europa, Catanzaro, Italy.
Regional Epilepsy Centre, Great Metropolitan Hospital, Via Melacrino, Reggio Calabria, Italy.

Edoardo Ferlazzo (E)

Medical and Surgical Sciences Department, School of Medicine, Magna Græcia University of Catanzaro, Viale Europa, Catanzaro, Italy.
Regional Epilepsy Centre, Great Metropolitan Hospital, Via Melacrino, Reggio Calabria, Italy.
Institute of Molecular Bioimaging and Physiology, National Research Council, Viale Europa, Catanzaro, Italy.

Chiara Sueri (C)

Regional Epilepsy Centre, Great Metropolitan Hospital, Via Melacrino, Reggio Calabria, Italy.

Vittoria Cianci (V)

Regional Epilepsy Centre, Great Metropolitan Hospital, Via Melacrino, Reggio Calabria, Italy.

Michele Ascoli (M)

Regional Epilepsy Centre, Great Metropolitan Hospital, Via Melacrino, Reggio Calabria, Italy.

Salvatore M Cavalli (SM)

Regional Epilepsy Centre, Great Metropolitan Hospital, Via Melacrino, Reggio Calabria, Italy.

Ettore Beghi (E)

Department of Neuroscience, IRCCS, Istituto di Ricerche Farmacologiche "Mario Negri", Milan, Italy.

Vincenzo Belcastro (V)

Neurology Unit, S. Anna Hospital, Como, Italy.

Amedeo Bianchi (A)

Department of Neurology and Epilepsy Centre, San Donato Hospital, Arezzo, Italy.

Paolo Benna (P)

Department of Neurosciences and Mental Health, Città della Salute e della Scienza University Hospital, Torino, Italy.

Roberto Cantello (R)

Neurology Unit, Department of Health Sciences, University of Piemonte Orientale, Novara, Italy.

Domenico Consoli (D)

Vibo Valentia Health Authority, Vibo Valentia, Italy.

Fabrizio A De Falco (FA)

Neurology Unit, Ospedale del Mare, Via Enrico Russo, Naples, Italy.

Giancarlo Di Gennaro (G)

IRCCS "NEUROMED", Pozzilli, Isernia, Italy.

Antonio Gambardella (A)

Medical and Surgical Sciences Department, School of Medicine, Magna Græcia University of Catanzaro, Viale Europa, Catanzaro, Italy.
Institute of Molecular Bioimaging and Physiology, National Research Council, Viale Europa, Catanzaro, Italy.

Gian Luigi Gigli (GL)

Neurology Unit, Department of Medicine (DAME), University of Udine Medical School, Udine, Italy.

Alfonso Iudice (A)

Department of Clinical and Experimental Medicine, Section of Neurology, University of Pisa, Pisa, Italy.

Angelo Labate (A)

Medical and Surgical Sciences Department, School of Medicine, Magna Græcia University of Catanzaro, Viale Europa, Catanzaro, Italy.
Institute of Molecular Bioimaging and Physiology, National Research Council, Viale Europa, Catanzaro, Italy.

Roberto Michelucci (R)

IRCCS Institute of Neurological Sciences, Neurology Unit, Bellaria Hospital, Bologna, Italy.

Maurizio Paciaroni (M)

Stroke Unit and Division of Cardiovascular Medicine, University of Perugia, Perugia, Italy.

Pasquale Palumbo (P)

Local Health Unit, Prato, Italy.

Alberto Primavera (A)

Clinical Neurology, Department of Neuroscience (DINOGMI), University of Genoa, IRCCS AOU San Martino-IST, Genoa, Italy.

Ferdinando Sartucci (F)

Department of Clinical and Experimental Medicine, Section of Neurology, University of Pisa, Pisa, Italy.

Pasquale Striano (P)

Pediatric Neurology and Muscular Diseases Unit, Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, "G. Gaslini" Institute, Genoa, Italy.

Flavio Villani (F)

Department of Diagnostics and Applied Technology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.

Emilio Russo (E)

Science of Health Department, School of Medicine, University "Magna Graecia" of Catanzaro, Viale Europa, Catanzaro, Italy.

Giovambattista De Sarro (G)

Science of Health Department, School of Medicine, University "Magna Graecia" of Catanzaro, Viale Europa, Catanzaro, Italy.

Umberto Aguglia (U)

Medical and Surgical Sciences Department, School of Medicine, Magna Græcia University of Catanzaro, Viale Europa, Catanzaro, Italy. u.aguglia@gmail.com.
Regional Epilepsy Centre, Great Metropolitan Hospital, Via Melacrino, Reggio Calabria, Italy. u.aguglia@gmail.com.
Institute of Molecular Bioimaging and Physiology, National Research Council, Viale Europa, Catanzaro, Italy. u.aguglia@gmail.com.
Regional Epilepsy Centre, Magna Graecia University of Catanzaro, Riuniti Hospital, Via Melacrino, Reggio Calabria, Italy. u.aguglia@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH